., N. (2023) “Effect of SGLT2 inhibitor (Empagliflozin) on HbA1c in most Prevalent Age Group of Type 2 Diabetic Patients”, International Journal of Pathology. Translated byF. Naim et al, 20(4), pp. 178–181. Available at: https://jpathology.com/index.php/OJS/article/view/802 (Accessed: 9 April 2025).